VANEK, Jakub, Jan PRASKO, Samuel GENZOR, Kamila BELOHRADOVA, Jozef VISNOVSKY, Jan MIZERA, Jonas BOCEK, Milan SOVA and Marie OCISKOVA. Cognitive Functions, Depressive and Anxiety Symptoms After One Year of CPAP Treatment in Obstructive Sleep Apnea. Psychology Research and Behavior Management. ALBANY: DOVE MEDICAL PRESS LTD, 2023, vol. 16, June 2023, p. 2253-2266. ISSN 1179-1578. Available from: https://dx.doi.org/10.2147/PRBM.S411465.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Cognitive Functions, Depressive and Anxiety Symptoms After One Year of CPAP Treatment in Obstructive Sleep Apnea
Authors VANEK, Jakub (203 Czech Republic), Jan PRASKO (203 Czech Republic, guarantor), Samuel GENZOR (203 Czech Republic), Kamila BELOHRADOVA (203 Czech Republic), Jozef VISNOVSKY (203 Czech Republic), Jan MIZERA (203 Czech Republic), Jonas BOCEK (203 Czech Republic), Milan SOVA (203 Czech Republic, belonging to the institution) and Marie OCISKOVA (203 Czech Republic).
Edition Psychology Research and Behavior Management, ALBANY, DOVE MEDICAL PRESS LTD, 2023, 1179-1578.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30203 Respiratory systems
Country of publisher New Zealand
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.300 in 2022
RIV identification code RIV/00216224:14110/23:00133291
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.2147/PRBM.S411465
UT WoS 001019850700001
Keywords in English obstructive sleep apnoea; depression; cognitive functions; CPAP treatment; treatment efficacy; Trail Making Test; Verbal; Fluency Test
Tags 14110215, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 29/1/2024 12:42.
Abstract
Objective: The study worked with depressive symptoms, anxiety score and cognitive functions in obstructive sleep apnea (OSA) patients treated with CPAP.Methods: Eighty-one subjects with OSA and without psychiatric comorbidity were treated with CPAP for one year and completed the following scales and cognitive tests: Trail Making Test, Verbal Fluency Test, d2 Test, Beck Depression Inventory-II and Beck Anxiety Inventory. MINI ruled out psychiatric disorder. At the two months check-up, subjects were re-evaluated for depressive and anxiety symptoms, and after one year of CPAP treatment, subjects repeated cognitive tests and scales. Data about therapy adherence and effectiveness were obtained from the patient's CPAP machines. Results: The study was completed by 59 CPAP adherent patients and eight non-adherent patients. CPAP therapy effectiveness was verified in all patients by decreasing the apnea-hypopnoea index below 5 and/or 10% of baseline values. The adherent patients significantly improved depressive and anxiety symptoms. There was also an improvement in overall performance in the attention test; however, performance in many individual items did not change. The adherent patients also improved verbal fluency and in the Part B of the Trail making test. The non-adherent group significantly increased the number of mistakes made in the d2 test; other resultsConclusion: According to our results, OSA patients' mood, anxiety and certain cognitive domains improved during the one-year therapy with CPAP.
PrintDisplayed: 17/7/2024 01:56